Compounded Tirzepatide vs AOD-9604

An honest, side-by-side look at two treatment options — so you and your provider can decide what may work best for you.

How Do They Compare?

Compounded Tirzepatide (Dual GIP/GLP-1 receptor agonist for weight management) and AOD-9604 (Modified growth hormone fragment for body composition) are both options in weight-management and peptide space. Compounded Tirzepatide Compounded tirzepatide is a dual GIP and GLP-1 receptor agonist that may support weight management by targeting two key hormonal pathways involved in appetite regulation and metabolism. AOD-9604 AOD-9604 is a modified fragment of human growth hormone that is being studied for its potential role in supporting fat metabolism without the growth-promoting effects of full GH. Your provider can help determine which treatment, if any, may be appropriate based on your individual health profile and goals.

All medications referenced on this page are compounded by a licensed 503A pharmacy and are not FDA-approved.

Side-by-Side Comparison

Compounded Tirzepatide

Available Now
$285/mo

If prescribed by a provider

Category

weight-management

Description

Dual GIP/GLP-1 receptor agonist for weight management

Features

  • Targets two hormonal pathways (GIP and GLP-1)
  • May help reduce appetite through dual mechanism
  • Weekly subcutaneous injection
  • Dosage gradually titrated under medical supervision

Considerations

  • Compounded medications are not FDA-approved
  • Common side effects may include nausea, diarrhea, and decreased appetite
  • Not suitable for individuals with a history of MEN 2
  • Requires ongoing provider monitoring
Get Started

AOD-9604

Coming Soon
Coming Soon

Join the waitlist to be notified

Category

peptide

Description

Modified growth hormone fragment for body composition

Features

  • Modified fragment of growth hormone
  • May support fat metabolism
  • Does not affect blood sugar or growth
  • Administered via subcutaneous injection

Considerations

  • Not FDA-approved
  • Research is still emerging
  • Side effects not fully characterized
  • Requires provider supervision
Join Waitlist

Frequently Asked Questions

Related Comparisons

AOD-9604 vs Lipo-MIC Injections

AOD-9604 vs Lipo-MIC Injections

AOD-9604 vs Vitamin B12 Injections

AOD-9604 vs Vitamin B12 Injections

CJC-1295 / Ipamorelin vs AOD-9604

CJC-1295 / Ipamorelin vs AOD-9604

PT-141 (Bremelanotide) vs AOD-9604

PT-141 (Bremelanotide) vs AOD-9604

BPC-157 vs AOD-9604

BPC-157 vs AOD-9604

NAD+ Therapy vs AOD-9604

NAD+ Therapy vs AOD-9604

Be the First to Know

One or more treatments on this page are coming soon. Join our waitlist to be notified when they become available, if prescribed by a provider.

Join the Waitlist

Dive Deeper

Learn more about Tirzepatide

Dual GIP/GLP-1 receptor agonist for weight management

Compounded tirzepatide is not FDA-approved. All treatments require evaluation and prescription by a licensed healthcare provider. Individual results may vary. This information is not intended to diagnose, treat, cure, or prevent any disease.

Ready to Explore Your Options?

Connect with a licensed provider who can help determine which treatment may be appropriate for your individual health goals.

Get Started

Ready to get started?

Talk to a licensed provider

Get Started